SKB565 clinical trial: Why Kelun-Biotech’s first dual-payload ADC matters
Kelun-Biotech’s SKB565 gains China clinical trial clearance, moving its first dual-payload ADC toward a Phase 1/2 solid-tumor study.
Pharma & Biotech